But unlike similar eye drops that arrived in recent years, VIZZ appears to avoid annoying side effects and rare medical complications. The usual solutions to the issue are either picking up a pair of reading glasses, or swapping your daily lenses or contact lenses for bifocals. But in 2021, the FDA approved a breakthrough eye drop treatment called Vuity, which uses pilocarpine hydrochloride to stimulate the pupil to contract. In rare cases, they cited vitreoretinal issues, or problems with the retina and vitreous fluid at the back of the eye. VIZZ’s manufacturer aims to have the eye drops widely available through prescription by the fourth quarter of 2025.